Sort
17,828 grants matching “crispr”
MECHANISMS OF POL II ELONGATION IN DIFFUSE MIDLINE GLIOMA
$473,032Jamie N. Anastas · Baylor College Of Medicine · R01 · FY2023 · NS
Mechanistic Basis of Circadian Clocks in Bmal1 Knockout Mice
$472,852Akhilesh Basi Reddy · University Of Pennsylvania · R01 · FY2021 · GM
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$472,823Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
The molecular genetic analysis of human obesity
$472,789Rudolph L Leibel · Columbia University Health Sciences · R01 · FY2016 · DK
Regulation of Vascular Integrity
$472,608Brant Weinstein · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Hematology Training Program
$472,599Margaret Goodell · Baylor College Of Medicine · T32 · FY2020 · DK
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$472,594Saar Gill · University Of Pennsylvania · P01 · FY2023 · CA
Therapeutic genome editing to treat Best disease
$472,500Bruce R Conklin · J. David Gladstone Institutes · R01 · FY2020 · EY
Project 3: CRISPR Genome Editing to Understand and Correct STAT3 GOF Immune Dysregulation
$472,500Alexander Marson · University Of California, San Francisco · P01 · FY2022 · AI
A Translatable Form of Hypoxia Therapy for Impaired Mitochondrial Proteostasis
$472,500Isha Himani Jain · J. David Gladstone Institutes · R56 · FY2024 · AG
Mapping cellular communication at single-cell resolution through novel CRISPR systems
$472,500Christof Fellmann · J. David Gladstone Institutes · R35 · FY2021 · GM
Regulation and Targeting of HIV-1 Integrase-RNA Interactions
$472,500Sebla B. Kutluay · Washington University · R01 · FY2022 · AI
Chemo-mediated transcriptional reprogramming in ovarian cancer
$472,316Mazhar Adli · Northwestern University At Chicago · R01 · FY2022 · CA
Molecular Genetics Of Early Eye Development
$472,309Stanislav I Tomarev · National Eye Institute · ZIA · FY2016 · EY
Investigation of impaired neural stem cell activation in Alzheimer's Disease
$472,287Ashley E Webb · Buck Institute For Research On Aging · R01 · FY2025 · AG
The function of the PRMT5 methylosome in MTAP deleted cancers
$472,119William R Sellers · Broad Institute, Inc. · R01 · FY2025 · CA
Image-guided radiation-induced permeability (IGRIP) for IGDD
$472,098Stephen J. Kron · University Of Chicago · R01 · FY2019 · CA
Biology and novel therapy of AML expressing somatic or germline mutant RUNX1
$472,065Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$472,040Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$472,040Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2021 · CA
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$472,040Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA
Mechanisms of Epidermal Homeostasis and Early Neoplasia
$472,026Paul A Khavari · Stanford University · R01 · FY2020 · AR
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
$472,000Bruce R Conklin · J. David Gladstone Institutes · R01 · FY2018 · HL
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
$472,000Bruce R Conklin · J. David Gladstone Institutes · R01 · FY2019 · HL
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
$472,000Bruce R Conklin · J. David Gladstone Institutes · R01 · FY2017 · HL